2016UWA Profiles and Research Repository (University of Western Australia)Requires access

The clinical significance of HLA antibodies detected by solid phase assay In renal transplant recipients

Samantha Fidler

Open publisher page 0 citations

Abstract

Kidney transplantation is the therapy of choice for end stage renal failure. One of the major immunological hurdles in transplantation is the presence of pre-formed antibodies in the recipient directed against donor HLA antigens. Donor specific anti-HLA antibodies are associated with allograft rejection and poor long term graft outcome. In recent years, the detection of anti-HLA antibodies has evolved from the relatively insensitive lymphocytotoxic crossmatch to the more sensitive solid phase assays including ELISA and Luminex bead assays. This thesis investigates the clinical significance of anti-HLA antibodies detected by Luminex single antigen bead assay on renal transplant outcome.

About this research paper

What this paper is about

Kidney transplantation is the therapy of choice for end stage renal failure. One of the major immunological hurdles in transplantation is the presence of pre-formed antibodies in the recipient directed against donor HLA antigens. Donor specific anti-HLA antibodies are associated with allograft rejection and poor long term graft outcome. In recent years, the detection of anti-HLA antibodies has evolved from the relatively insensitive lymphocytotoxic crossmatch to the more sensitive solid phase assays including ELISA and Luminex bead assays. This thesis investigates the clinical significance of anti-HLA antibodies detected by Luminex single antigen bead assay on renal transplant outcome.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Kidney transplantation is the therapy of choice for end stage renal failure. One of the major immunological hurdles in transplantation is the presence of pre-formed antibodies in the recipient directed against donor HLA antigens. Donor specific anti-HLA antibodies are associated with allograft rejection and poor long term graft outcome. In recent years, the detection of anti-HLA antibodies has evolved from the relatively insensitive lymphocytotoxic crossmatch to the more sensitive solid phase assays including ELISA and Luminex bead assays. This thesis investigates the clinical significance of anti-HLA antibodies detected by Luminex single antigen bead assay on renal transplant outcome.

Key concepts: Renal transplant, Human leukocyte antigen, Medicine, Antibody, Clinical significance, Immunology, Kidney transplantation, Transplantation

Related papers

Back to paper searchBrowse research topicsOriginal source
The clinical significance of HLA antibodies detected by solid phase assay In renal transplant recipients — Research Paper | ScholarLens